R. Osieka

SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma

Oliver Galm, Hirohide Yoshikawa, Manel Esteller et al. · Blood · 2003 · 306 citations

Life Sciences, Cell Biology, Molecular Biology +12

Clinical pharmacology of sodium butyrate in patients with acute leukemia

Antonius A. Miller, E. Kurschel, R. Osieka et al. · European Journal of Cancer and Clinical Oncology · 1987 · 251 citations

Medicine, Pharmacokinetics, Pharmacology +12

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

Stefan Wilop, Sabine von Hobe, Martina Crysandt et al. · Journal of Cancer Research and Clinical Oncology · 2009 · 163 citations · Full text

Medicine, Oncology, Pharmacology +8

Positron emission tomography with 18F-FDG to detect residual disease after therapy for malignant lymphoma

U. Cremerius, U. Fabry, J. Neuerburg et al. · Nuclear Medicine Communications · 1998 · 142 citations

Medicine, Nuclear Medicine, Radiology +17

DNA methylation changes in multiple myeloma

Oliver Galm, Stefan Wilop, Julia Reichelt et al. · Leukemia · 2004 · 127 citations

Medicine, Genetics, Molecular Biology +14